Cementos Argos vs UnitedHealth Which Is More Lucrative?

Cementos Argos and UnitedHealth are two companies operating in very different industries, but both are major players in their respective sectors. Cementos Argos is a leading cement and construction materials company, while UnitedHealth is one of the largest health insurance providers in the United States. Both stocks have shown strong performance in recent years, with Cementos Argos benefiting from increased infrastructure investment and UnitedHealth benefiting from the growing demand for healthcare services. Investors looking for growth and stability may consider these two stocks for their portfolio.

Cementos Argos or UnitedHealth?

When comparing Cementos Argos and UnitedHealth, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Cementos Argos and UnitedHealth.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Cementos Argos has a dividend yield of 0.0%, while UnitedHealth has a dividend yield of 2.25%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Cementos Argos reports a 5-year dividend growth of 2.92% year and a payout ratio of 235.21%. On the other hand, UnitedHealth reports a 5-year dividend growth of 0.00% year and a payout ratio of 50.63%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Cementos Argos P/E ratio at 269.10 and UnitedHealth's P/E ratio at 1.41. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Cementos Argos P/B ratio is 4.43 while UnitedHealth's P/B ratio is 0.22.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Cementos Argos has seen a 5-year revenue growth of 0.49%, while UnitedHealth's is 0.71%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Cementos Argos's ROE at 1.96% and UnitedHealth's ROE at 15.92%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $9.98 for Cementos Argos and C$29.45 for UnitedHealth. Over the past year, Cementos Argos's prices ranged from $6.15 to $12.61, with a yearly change of 105.04%. UnitedHealth's prices fluctuated between C$21.03 and C$30.05, with a yearly change of 42.89%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.